Joseph Baroldi's Insider Trades & SAST Disclosures
Joseph Baroldi's most recent trade in Ionis Pharmaceuticals Inc was a trade of 33,000 Restricted Stock Unit done . Disclosure was reported to the exchange on Jan. 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Joseph Baroldi.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 33,000 | 86,135 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 22,000 | 51,290 | - | - | Performance Restricted Stock Units | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 8,787 | 28,418 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 8,787 | 77,348 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 3,750 | 10,784 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 32.70 per share. | 15 Jan 2025 | 3,401 | 25,017 (0%) | 0% | 32.7 | 111,213 | Common Stock |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 2,460 | 8,324 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 2,460 | 4,100 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 32.70 per share. | 15 Jan 2025 | 1,029 | 3,071 (0%) | 0% | 32.7 | 33,648 | Common Stock |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 22,000 | 22,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 2,500 | 2,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 10,838 | 53,135 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 10,838 | 23,637 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 41.60 per share. | 15 Apr 2024 | 4,006 | 19,631 (0%) | 0% | 41.6 | 166,641 | Common Stock |
| Ionis Pharmaceuticals Inc | Baroldi T. Joseph | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2024 | 3,688 | 14,259 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Baroldi Joseph T. | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2024 | 3,688 | 63,973 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | T. Joseph Baroldi | EVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 50.42 per share. | 16 Jan 2024 | 1,460 | 12,799 (0%) | 0% | 50.4 | 73,609 | Common Stock |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2024 | 1,353 | 2,204 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2024 | 1,353 | 7,034 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | T. Joseph Baroldi | EVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 50.42 per share. | 16 Jan 2024 | 564 | 1,640 (0%) | 0% | 50.4 | 28,435 | Common Stock |
| Ionis Pharmaceuticals Inc | Joseph Baroldi T. | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 20,400 | 67,661 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Baroldi T. Joseph | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 17,000 | 29,290 | - | - | Performance Restricted Stock Units | |
| Ionis Pharmaceuticals Inc | Joseph Baroldi T. | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 2,625 | 8,387 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Baroldi T. Joseph | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 1,800 | 5,762 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 27,200 | 27,200 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Baroldi T. Joseph | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 3,500 | 3,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 10,838 | 14,451 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 10,838 | 47,261 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 36.50 per share. | 17 Apr 2023 | 3,880 | 10,571 (0%) | 0% | 36.5 | 141,631 | Common Stock |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 904 | 1,226 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 904 | 3,962 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 39.79 per share. | 17 Jan 2023 | 375 | 851 (0%) | 0% | 39.8 | 14,920 | Common Stock |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2023 | 14,749 | 58,099 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2023 | 12,290 | 12,290 | - | - | Performance Restricted Stock Units | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2023 | 1,800 | 4,866 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 19,665 | 19,665 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 2,400 | 2,400 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2022 | 43,350 | 43,350 | - | - | Restricted Stock Unit | |
| Ionis Pharmaceuticals Inc | Joseph T. Baroldi | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 86,700 | 86,700 | - | - | Non-Qualified Stock Option (right to buy) | |
| Avidity Biosciences Inc | Joseph Baroldi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 87,000 | 87,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges